RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재 SCOPUS SCIE OpenAccess

    ABO 부적합 신장 이식 후 발생한 가역적 후백질 뇌병증 증후군 1예 = A Case of Reversible Posterior Leukoencephalopathy Syndrome in a Patient with ABO Incompatible Kidney Transplantation

    한글로보기

    https://www.riss.kr/link?id=A104778688

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
      • URL 복사
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Reversible posterior leukoencepalopathy syndrome (RPLS) was noted by a reversible syndrome of headache, altered mental status, seizure, and visual loss associated with findings indicating predominantly posterior leukoencephalopathy on imaging studies. We report a successful treatment of RPLS after secondary ABO incompatibility kidney transplantation with blood pressure control. A 41-year-old female whose primary kidney disease was chronic glomerulonephritis had graft failure developed after living donor kidney transplantation (1st kidney transplantation). She was admitted to our hospital for 2nd ABO incompatibility kidney transplantation. She had undergone 6 times of plasmapheresis and received additional two doses of rituximab (375 mg/m2) and intravenous immunoglobulin (0.5 g/kg) before kidney transplantation. She received basiliximab induction therapy, tacrolimus, steroid and mycophenolate mofetile after transplantation. The ABO antibody titer had been low (below 1:1) and evidences of rejection were not detected. Generalized tonic clonic type seizure, eyeball deviation, facial cyanotic change and loss of consciousness occurred at post operation 7th day. Several minutes later, she recovered her consciousness without disability and neurologic deficit. She did not represent attacks any more after we controlled blood pressure without withdrawal of immunosuppressants or dose reduction.
    번역하기

    Reversible posterior leukoencepalopathy syndrome (RPLS) was noted by a reversible syndrome of headache, altered mental status, seizure, and visual loss associated with findings indicating predominantly posterior leukoencephalopathy on imaging studies....

    Reversible posterior leukoencepalopathy syndrome (RPLS) was noted by a reversible syndrome of headache, altered mental status, seizure, and visual loss associated with findings indicating predominantly posterior leukoencephalopathy on imaging studies. We report a successful treatment of RPLS after secondary ABO incompatibility kidney transplantation with blood pressure control. A 41-year-old female whose primary kidney disease was chronic glomerulonephritis had graft failure developed after living donor kidney transplantation (1st kidney transplantation). She was admitted to our hospital for 2nd ABO incompatibility kidney transplantation. She had undergone 6 times of plasmapheresis and received additional two doses of rituximab (375 mg/m2) and intravenous immunoglobulin (0.5 g/kg) before kidney transplantation. She received basiliximab induction therapy, tacrolimus, steroid and mycophenolate mofetile after transplantation. The ABO antibody titer had been low (below 1:1) and evidences of rejection were not detected. Generalized tonic clonic type seizure, eyeball deviation, facial cyanotic change and loss of consciousness occurred at post operation 7th day. Several minutes later, she recovered her consciousness without disability and neurologic deficit. She did not represent attacks any more after we controlled blood pressure without withdrawal of immunosuppressants or dose reduction.

    더보기

    참고문헌 (Reference)

    1 최원준, "고혈압성 뇌병증 환자의 확산강조 자기공명영상 소견: 1례 보고" 대한뇌졸중학회 2 (2): 99-102, 2000

    2 Akutsu N, "Two cases of calcineurin inhibitor associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients" 40 : 2416-2418, 2008

    3 류지연, "Postpartum Cerebral Angiopathy 1례" 대한뇌졸중학회 2 (2): 91-94, 2000

    4 Antunes NL, "Posterior leukoencephalopathy syndrome may not be reversible" 20 : 241-243, 1999

    5 Garg RK, "Posterior leukoencephalopathy syndrome" 77 : 24-28, 2001

    6 Barshes NR, "Pharmacologic immunosuppression" 9 : 411-420, 2004

    7 Truwit CL, "MR imaging of reversible cyclosporine A-induced neurotoxicity" 12 : 651-659, 1991

    8 Jordan SC, "Is Rituximab safe to use in kidney transplant patients?" 10 : 8-9, 2010

    9 Cooney MJ, "Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders-report of three cases" 214 : 711-716, 2000

    10 Wijdicks EF, "FK506-induced neurotoxicity in liver transplantation" 35 : 498-501, 1994

    1 최원준, "고혈압성 뇌병증 환자의 확산강조 자기공명영상 소견: 1례 보고" 대한뇌졸중학회 2 (2): 99-102, 2000

    2 Akutsu N, "Two cases of calcineurin inhibitor associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients" 40 : 2416-2418, 2008

    3 류지연, "Postpartum Cerebral Angiopathy 1례" 대한뇌졸중학회 2 (2): 91-94, 2000

    4 Antunes NL, "Posterior leukoencephalopathy syndrome may not be reversible" 20 : 241-243, 1999

    5 Garg RK, "Posterior leukoencephalopathy syndrome" 77 : 24-28, 2001

    6 Barshes NR, "Pharmacologic immunosuppression" 9 : 411-420, 2004

    7 Truwit CL, "MR imaging of reversible cyclosporine A-induced neurotoxicity" 12 : 651-659, 1991

    8 Jordan SC, "Is Rituximab safe to use in kidney transplant patients?" 10 : 8-9, 2010

    9 Cooney MJ, "Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders-report of three cases" 214 : 711-716, 2000

    10 Wijdicks EF, "FK506-induced neurotoxicity in liver transplantation" 35 : 498-501, 1994

    11 Schwartz RB, "Diffusion-weighted MR imaging in hypertensive encephalopathy: Clues to pathogenesis" 19 : 859-862, 1998

    12 Gijtenbeek JM, "Cyclosporine neurotoxicity: a review" 246 : 339-346, 1999

    13 Kim BK, "Cerebral vasospasm in eclampsia: Report of a case" 15 : 394-398, 1997

    14 Sanders TG, "Brain in eclampsia: MR imaging with clinical correlation" 180 : 475-478, 1991

    15 Hinchey J, "A reversible posterior leukoencephalopathy syndrome" 334 : 494-500, 1996

    16 Ji KT, "A case of reversible posterior leukoencephalopathy after rhabdomyolysis" 19 : 163-166, 2001

    더보기

    동일학술지(권/호) 다른 논문

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
    2020-01-01 등재 등재학술지 유지 (해외등재 학술지 평가) KCI등재
    2011-11-29 학술지명변경 한글명 : The Korean Journal of Nephrology -> Kidney Research and Clinical Practice
    외국어명 : 미등록 -> Kidney Research and Clinical Practice
    KCI등재
    2010-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2008-01-01 등재 등재학술지 유지 (등재유지) KCI등재
    2007-02-22 학술지명변경 한글명 : 대한신장학회지 -> The Korean Society of Nephrology KCI등재
    2007-02-22 학술지명변경 한글명 : 대한신장학회지 -> The Korean Journal of Nephrology KCI등재
    2005-01-01 등재 등재학술지 선정 (등재후보2차) KCI등재
    2004-01-01 등재 등재후보 1차 PASS (등재후보1차) KCI등재후보
    2002-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2024 3.08 0.41 0
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0 0 0.48 0.03
    더보기
    해외이동버튼